Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.
Rishi J DesaiElisabetta PatornoMuthiah VaduganathanMufaddal MahesriKristyn ChinRaisa LevinScott D SolomonSebastian SchneeweissPublished in: Heart (British Cardiac Society) (2021)
ARNI treatment was associated with lower risk of a composite effectiveness endpoint compared with RAS blockade alone in older adults with HFrEF.